{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:28:04Z","timestamp":1789738084406,"version":"4.0.1"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001703","name":"\u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["945298"],"award-info":[{"award-number":["945298"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013000","name":"Politecnico di Torino","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jtbi.2024.111957","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T21:39:38Z","timestamp":1728077978000},"page":"111957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The development of drug resistance in metastatic tumours under chemotherapy: An evolutionary perspective"],"prefix":"10.1016","volume":"595","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9308-6176","authenticated-orcid":false,"given":"Federica","family":"Padovano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-0532","authenticated-orcid":false,"given":"Chiara","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtbi.2024.111957_b1","series-title":"Pharmacokinetics of Drugs Following IV Bolus, IV Infusion, and Oral Administration, Vol. 10","author":"Ahmed","year":"2015"},{"issue":"5","key":"10.1016\/j.jtbi.2024.111957_b2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00285-023-01996-4","article-title":"Adaptation in a heterogeneous environment II: To be three or not to be","volume":"87","author":"Alfaro","year":"2023","journal-title":"J. Math. Biol."},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1051\/m2an\/2019010","article-title":"Evolution of cancer cell populations under cytotoxic therapy and treatment optimisation: insight from a phenotype-structured model","volume":"53","author":"Almeida","year":"2019","journal-title":"ESAIM Math. Model. Numer. Anal."},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/cancers12040931","article-title":"Population pharmacokinetics\/pharmacodynamics of dabrafenib plus trametinib in patients with BRAF-mutated metastatic melanoma","volume":"12","author":"Balakirouchenane","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.jtbi.2024.111957_b5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1215\/S0012-7094-90-06132-0","article-title":"Wavefront propagation for reaction\u2013diffusion systems of PDE","volume":"61","author":"Barles","year":"1990","journal-title":"Duke Math. J."},{"issue":"3","key":"10.1016\/j.jtbi.2024.111957_b6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4310\/MAA.2009.v16.n3.a4","article-title":"Concentration in Lotka\u2013Volterra parabolic or integral equations: a general convergence result","volume":"16","author":"Barles","year":"2009","journal-title":"Methods Appl. Anal."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s42003-022-03595-3","article-title":"Eco-evolutionary model on spatial graphs reveals how habitat structure affects phenotypic differentiation","volume":"5","author":"Boussange","year":"2022","journal-title":"Commun. Biol."},{"issue":"3","key":"10.1016\/j.jtbi.2024.111957_b8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2217\/mmt.15.21","article-title":"Dabrafenib and its use in the treatment of metastatic melanoma","volume":"2","author":"Bowyer","year":"2015","journal-title":"Melanoma Manag."},{"key":"10.1016\/j.jtbi.2024.111957_b9","series-title":"The mechanics of metastasis: insights from a computational model","author":"Brodl","year":"2012"},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.18632\/oncotarget.2677","article-title":"The landscape of metastatic progression patterns across major human cancers","volume":"6","author":"Budczies","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.jtbi.2024.111957_b11","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtbi.2024.111957_b12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.matcom.2022.07.002","article-title":"Modeling metastatic tumor evolution, numerical resolution and growth prediction","volume":"203","author":"Bulai","year":"2023","journal-title":"Math. Comput. Simulation"},{"key":"10.1016\/j.jtbi.2024.111957_b13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.887366","article-title":"The dark side of melanin secretion in cutaneous melanoma aggressiveness","volume":"12","author":"Cabaco","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.cpc.2010.12.039","article-title":"From screening to quantitative sensitivity analysis. A unified approach","volume":"182","author":"Campolongo","year":"2011","journal-title":"Comput. Phys. Comm."},{"issue":"11","key":"10.1016\/j.jtbi.2024.111957_b15","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/j.bbagen.2016.06.009","article-title":"Cell population heterogeneity and evolution towards drug resistance in cancer: biological and mathematical assessment","volume":"1860","author":"Chisholm","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b16","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4310\/CMS.2016.v14.n4.a16","article-title":"Effects of an advection term in nonlocal Lotka\u2013Volterra equations","volume":"14","author":"Chisholm","year":"2016","journal-title":"Commun. Math. Sci."},{"issue":"6","key":"10.1016\/j.jtbi.2024.111957_b17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/0008-5472.CAN-14-2103","article-title":"Emergence of drug tolerance in cancer cell populations: an evolutionary outcome of selection, nongenetic instability, and stress-induced adaptation","volume":"75","author":"Chisholm","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.jtbi.2024.111957_b18","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1007\/s11538-017-0359-1","article-title":"Modeling the dynamics of heterogeneity of solid tumors in response to chemotherapy","volume":"79","author":"Cho","year":"2017","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.jtbi.2024.111957_b19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.apm.2018.07.025","article-title":"Modeling continuous levels of resistance to multidrug therapy in cancer","volume":"64","author":"Cho","year":"2018","journal-title":"Appl. Math. Model."},{"key":"10.1016\/j.jtbi.2024.111957_b20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jtbi.2017.10.005","article-title":"Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth","volume":"436","author":"Cho","year":"2018","journal-title":"J. Theoret. Biol."},{"key":"10.1016\/j.jtbi.2024.111957_b21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1051\/mmnp\/2019043","article-title":"The impact of competition between cancer cells and healthy cells on optimal drug delivery","volume":"15","author":"Cho","year":"2020","journal-title":"Math. Model. Nat. Phenom."},{"key":"10.1016\/j.jtbi.2024.111957_b22","article-title":"Cancer chemotherapy","author":"Chu","year":"2004","journal-title":"Basic Clin. Pharmacol."},{"key":"10.1016\/j.jtbi.2024.111957_b23","first-page":"1","article-title":"An evolutionary perspective on cancer, with applications to anticancer drug resistance modelling and perspectives in therapeutic control","author":"Clairambault","year":"2019","journal-title":"J. Math. Study"},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.11145\/j.biomath.2019.05.147","article-title":"A survey of adaptive cell population dynamics models of emergence of drug resistance in cancer, and open questions about evolution and cancer","volume":"8","author":"Clairambault","year":"2019","journal-title":"Biomath"},{"issue":"12","key":"10.1016\/j.jtbi.2024.111957_b25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.mpmed.2011.09.012","article-title":"Cytotoxic chemotherapy: clinical aspects","volume":"39","author":"Corrie","year":"2011","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.jtbi.2024.111957_b26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.diii.2013.10.010","article-title":"Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI","volume":"94","author":"Cuenod","year":"2013","journal-title":"Diagn. Interv. Imaging"},{"issue":"2","key":"10.1016\/j.jtbi.2024.111957_b27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jtbi.2024.111957_b28","series-title":"Seminars in Cancer Biology, Vol. 60","first-page":"351","article-title":"Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion","author":"D\u2019Alterio","year":"2020"},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tpb.2011.01.001","article-title":"A mathematical model for progression and heterogeneity in colorectal cancer dynamics","volume":"79","author":"Delitala","year":"2011","journal-title":"Theor. Popul. Biol."},{"issue":"3","key":"10.1016\/j.jtbi.2024.111957_b30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4310\/CMS.2008.v6.n3.a10","article-title":"On selection dynamics for continuous structured populations","volume":"6","author":"Desvillettes","year":"2008","journal-title":"Commun. Math. Sci."},{"key":"10.1016\/j.jtbi.2024.111957_b31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00285-012-0565-2","article-title":"Modeling the connection between primary and metastatic tumors","volume":"67","author":"Diego","year":"2013","journal-title":"J. Math. Biol."},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tpb.2004.12.003","article-title":"The dynamics of adaptation: an illuminating example and a Hamilton\u2013Jacobi approach","volume":"67","author":"Diekmann","year":"2005","journal-title":"Theor. Popul. Biol."},{"key":"10.1016\/j.jtbi.2024.111957_b33","series-title":"DNA Methylation: Development, Genetic Disease and Cancer, Vol. 310","author":"Doerfler","year":"2006"},{"issue":"26","key":"10.1016\/j.jtbi.2024.111957_b34","doi-asserted-by":"crossref","first-page":"14295","DOI":"10.1073\/pnas.97.26.14295","article-title":"Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy","volume":"97","author":"Duesberg","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jtbi.2024.111957_b35","series-title":"EMA\/CHMP\/242419\/2013\/corr 1 - CHMP assessment report: Tafinlar","author":"European Medicine Agency","year":"2013"},{"key":"10.1016\/j.jtbi.2024.111957_b36","series-title":"Partial Differential Equations, Vol. 19","author":"Evans","year":"2022"},{"issue":"6","key":"10.1016\/j.jtbi.2024.111957_b37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.jtbi.2024.111957_b38","first-page":"171","article-title":"PDE-viscosity solution approach to some problems of large deviations","volume":"13","author":"Fleming","year":"1986","journal-title":"Ann. Sc. Norm. Super Pisa Cl. Sci."},{"key":"10.1016\/j.jtbi.2024.111957_b39","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s11538-019-00597-x","article-title":"A mathematical framework for modelling the metastatic spread of cancer","volume":"81","author":"Franssen","year":"2019","journal-title":"Bull. Math. Biol."},{"issue":"23","key":"10.1016\/j.jtbi.2024.111957_b40","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1158\/1078-0432.CCR-04-0822","article-title":"Pharmacokinetic model-predicted anticancer drug concentrations in human tumors","volume":"10","author":"Gallo","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"15","key":"10.1016\/j.jtbi.2024.111957_b41","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1002\/mma.3887","article-title":"A mixed radiotherapy and chemotherapy model for treatment of cancer with metastasis","volume":"39","author":"Ghaffari","year":"2016","journal-title":"Math. Methods Appl. Sci."},{"issue":"7","key":"10.1016\/j.jtbi.2024.111957_b42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrc3298","article-title":"Evolutionary dynamics of carcinogenesis and why targeted therapy does not work","volume":"12","author":"Gillies","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2007.02.006","article-title":"HIF-2\u03b1 promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity","volume":"11","author":"Gordan","year":"2007","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b45","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","article-title":"Cancer metastasis: building a framework","volume":"127","author":"Gupta","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jtbi.2024.111957_b46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00285-021-01637-8","article-title":"Adaptation in a heterogeneous environment I: persistence versus extinction","volume":"83","author":"Hamel","year":"2021","journal-title":"J. Math. Biol."},{"issue":"22","key":"10.1016\/j.jtbi.2024.111957_b47","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.1158\/0008-5472.CAN-14-0721","article-title":"Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing mice","volume":"74","author":"Hartung","year":"2014","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jtbi.2024.111957_b48","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/pharmaceutics12050408","article-title":"Towards a quantitative mechanistic understanding of localized pulmonary tissue retention\u2014A combined in vivo\/in silico approach based on four model drugs","volume":"12","author":"Himstedt","year":"2020","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.jtbi.2024.111957_b49","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1124\/dmd.119.087973","article-title":"Prediction of tissue-plasma partition coefficients using microsomal partitioning: Incorporation into physiologically based pharmacokinetic models and steady-state volume of distribution predictions","volume":"47","author":"Holt","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jtbi.2024.111957_b50","article-title":"Selection-Mutation dynamics with spatial dependence","volume":"176","author":"Jabin","year":"2016","journal-title":"J. Math. Pures Appl."},{"issue":"8","key":"10.1016\/j.jtbi.2024.111957_b51","first-page":"1","article-title":"Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development","volume":"2","author":"Jones","year":"2013","journal-title":"CPT: Pharmacomet. Syst. Pharmacol."},{"key":"10.1016\/j.jtbi.2024.111957_b52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10585-017-9870-x","article-title":"Chemotherapy-induced metastasis: mechanisms and translational opportunities","volume":"35","author":"Karagiannis","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"issue":"15","key":"10.1016\/j.jtbi.2024.111957_b53","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1021\/ie900139x","article-title":"Global sensitivity analysis challenges in biological systems modeling","volume":"48","author":"Kiparissides","year":"2009","journal-title":"Ind. Eng. Chem. Res."},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b54","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.jtbi.2024.111957_b55","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1158\/0008-5472.CAN-13-1768","article-title":"The role of cell density and intratumoral heterogeneity in multidrug resistance","volume":"73","author":"Lavi","year":"2013","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.jtbi.2024.111957_b56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.molmed.2013.12.005","article-title":"Simplifying the complexity of resistance heterogeneity in metastasis","volume":"20","author":"Lavi","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"10","key":"10.1016\/j.jtbi.2024.111957_b57","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/1097-0142(19821115)50:10<2066::AID-CNCR2820501017>3.0.CO;2-X","article-title":"The glucose distribution in 9L rat brain multicell tumor spheroids and its effect on cell necrosis","volume":"50","author":"Li","year":"1982","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jtbi.2024.111957_b58","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/720439","article-title":"Multimorph eco-evolutionary dynamics in structured populations","volume":"200","author":"Lion","year":"2022","journal-title":"Amer. Nat."},{"issue":"7","key":"10.1016\/j.jtbi.2024.111957_b59","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/annonc\/mdx176","article-title":"Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E\/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study","volume":"28","author":"Long","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jtbi.2024.111957_b60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13062-016-0143-4","article-title":"Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations","volume":"11","author":"Lorenzi","year":"2016","journal-title":"Biol. Direct"},{"key":"10.1016\/j.jtbi.2024.111957_b61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtbi.2018.05.002","article-title":"The role of spatial variations of abiotic factors in mediating intratumour phenotypic heterogeneity","volume":"451","author":"Lorenzi","year":"2018","journal-title":"J. Theoret. Biol."},{"issue":"6","key":"10.1016\/j.jtbi.2024.111957_b62","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/03605302.2010.538784","article-title":"Dirac mass dynamics in multidimensional nonlocal parabolic equations","volume":"36","author":"Lorz","year":"2011","journal-title":"Comm. Partial Differential Equations"},{"key":"10.1016\/j.jtbi.2024.111957_b63","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fonc.2019.00268","article-title":"Diverse mechanisms of BRAF inhibitor resistance in melanoma identified in clinical and preclinical studies","volume":"9","author":"Luebker","year":"2019","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.jtbi.2024.111957_b64","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/CMR.0000000000000608","article-title":"Effectiveness of dabrafenib in the treatment of patients with BRAF V600\u2013mutated metastatic melanoma in a Named Patient Program","volume":"29","author":"Martin-Algarra","year":"2019","journal-title":"Melanoma Res."},{"issue":"7586","key":"10.1016\/j.jtbi.2024.111957_b65","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jtbi.2024.111957_b66","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jtbi.2006.01.006","article-title":"Dynamics of metastasis suppressor gene inactivation","volume":"241","author":"Michor","year":"2006","journal-title":"J. Theoret. Biol."},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jtbi.2005.10.021","article-title":"Stochastic dynamics of metastasis formation","volume":"240","author":"Michor","year":"2006","journal-title":"J. Theoret. Biol."},{"issue":"3","key":"10.1016\/j.jtbi.2024.111957_b68","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3934\/dcdsb.2013.18.753","article-title":"Adaptation and migration of a population between patches","volume":"18","author":"Mirrahimi","year":"2012","journal-title":"Discrete Contin. Dyn. Syst. Ser. B"},{"issue":"2","key":"10.1016\/j.jtbi.2024.111957_b69","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1534\/genetics.119.302868","article-title":"Evolution of specialization in heterogeneous environments: equilibrium between selection, mutation and migration","volume":"214","author":"Mirrahimi","year":"2020","journal-title":"Genetics"},{"issue":"6","key":"10.1016\/j.jtbi.2024.111957_b70","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.matpur.2015.07.006","article-title":"Asymptotic analysis of a selection model with space","volume":"104","author":"Mirrahimi","year":"2015","journal-title":"J. Math. Pures Appl."},{"issue":"3","key":"10.1016\/j.jtbi.2024.111957_b71","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/jpet.112.201475","article-title":"Mechanisms limiting distribution of the threonine-protein kinase B-RaFV600E inhibitor dabrafenib to the brain: implications for the treatment of melanoma brain metastases","volume":"344","author":"Mittapalli","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"17","key":"10.1016\/j.jtbi.2024.111957_b72","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1111\/bph.12604","article-title":"Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling","volume":"171","author":"Moss","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.jtbi.2024.111957_b73","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1158\/0008-5472.CAN-12-4488","article-title":"Spreaders and sponges define metastasis in lung cancer: a markov chain monte carlo mathematical model","volume":"73","author":"Newton","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npjbcancer.2015.18","article-title":"Spatiotemporal progression of metastatic breast cancer: a markov chain model highlighting the role of early metastatic sites","volume":"1","author":"Newton","year":"2015","journal-title":"NPJ Breast Cancer"},{"issue":"5","key":"10.1016\/j.jtbi.2024.111957_b75","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2101","article-title":"Genetic determinants of cancer metastasis","volume":"8","author":"Nguyen","year":"2007","journal-title":"Nature Rev. Genet."},{"issue":"7\u20138","key":"10.1016\/j.jtbi.2024.111957_b76","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.mcm.2005.09.026","article-title":"Modelling the response of spatially structured tumours to chemotherapy: Drug kinetics","volume":"43","author":"Norris","year":"2006","journal-title":"Math. Comput. Modelling"},{"issue":"7547","key":"10.1016\/j.jtbi.2024.111957_b77","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature14336","article-title":"Therapy-induced tumour secretomes promote resistance and tumour progression","volume":"520","author":"Obenauf","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2024.111957_b78","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbs.2024.109207","article-title":"Mathematical modeling of brain metastases growth and response to therapies: A review","author":"Oca\u00f1a-Tienda","year":"2024","journal-title":"Math. Biosci."},{"key":"10.1016\/j.jtbi.2024.111957_b79","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10957-018-01461-z","article-title":"Combination of direct methods and homotopy in numerical optimal control: application to the optimization of chemotherapy in cancer","volume":"181","author":"Olivier","year":"2019","journal-title":"J. Optim. Theory Appl."},{"issue":"10","key":"10.1016\/j.jtbi.2024.111957_b80","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/onc.2015.192","article-title":"The biology of circulating tumor cells","volume":"35","author":"Pantel","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.jtbi.2024.111957_b81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10585-021-10144-5","article-title":"Current challenges in metastasis research and future innovation for clinical translation","volume":"39","author":"Parker","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.jtbi.2024.111957_b82","series-title":"Transport Equations in Biology","author":"Perthame","year":"2006"},{"key":"10.1016\/j.jtbi.2024.111957_b83","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1512\/iumj.2008.57.3398","article-title":"Dirac concentrations in Lotka\u2013Volterra parabolic pdes","author":"Perthame","year":"2008","journal-title":"Indiana Univ. Math. J."},{"key":"10.1016\/j.jtbi.2024.111957_b84","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.matpur.2017.10.007","article-title":"Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy","volume":"116","author":"Pouchol","year":"2018","journal-title":"J. Math. Pures Appl."},{"key":"10.1016\/j.jtbi.2024.111957_b85","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s40262-018-0703-0","article-title":"Clinical pharmacokinetics and pharmacodynamics of dabrafenib","volume":"58","author":"Puszkiel","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jtbi.2024.111957_b86","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbs.2020.108306","article-title":"Sensitivity analysis methods in the biomedical sciences","volume":"323","author":"Qian","year":"2020","journal-title":"Math. Biosci."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b87","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/6\/1\/016008","article-title":"Multi-scale modelling of cancer cell intravasation: the role of cadherins in metastasis","volume":"6","author":"Ramis-Conde","year":"2009","journal-title":"Phys. Biol."},{"issue":"2","key":"10.1016\/j.jtbi.2024.111957_b88","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0010-4655(02)00280-1","article-title":"Making best use of model evaluations to compute sensitivity indices","volume":"145","author":"Saltelli","year":"2002","journal-title":"Comput. Phys. Comm."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b89","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12976-021-00142-1","article-title":"How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer","volume":"18","author":"Schlicke","year":"2021","journal-title":"Theor. Biol. Med. Model."},{"issue":"82","key":"10.1016\/j.jtbi.2024.111957_b90","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2013.0011","article-title":"A mathematical model of tumour self-seeding reveals secondary metastatic deposits as drivers of primary tumour growth","volume":"10","author":"Scott","year":"2013","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.jtbi.2024.111957_b91","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-94-007-7835-1_9","article-title":"Mathematical modeling of the metastatic process","author":"Scott","year":"2013","journal-title":"Exp. Metastasis Model. Anal."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jtbi.2024.111957_b93","series-title":"Physiology, Blood Volume","author":"Sharma","year":"2022"},{"issue":"10","key":"10.1016\/j.jtbi.2024.111957_b94","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: the mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b95","doi-asserted-by":"crossref","first-page":"22498","DOI":"10.1038\/srep22498","article-title":"Mathematical modeling of therapy-induced cancer drug resistance: connecting cancer mechanisms to population survival rates","volume":"6","author":"Sun","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtbi.2024.111957_b96","series-title":"Metastatic Melanoma","author":"Sundararajan","year":"2022"},{"issue":"8","key":"10.1016\/j.jtbi.2024.111957_b97","first-page":"3058","article-title":"Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases","volume":"41","author":"Tsuruo","year":"1981","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jtbi.2024.111957_b98","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/S1470-2045(11)70335-7","article-title":"Genetic heterogeneity and cancer drug resistance","volume":"13","author":"Turner","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jtbi.2024.111957_b99","series-title":"Dabrafenib (tafinlar) pharmacology review","author":"US Food and Drug Administration","year":"2013"},{"key":"10.1016\/j.jtbi.2024.111957_b100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10013-020-00445-9","article-title":"Evolutionary dynamics in vascularised tumours under chemotherapy: Mathematical modelling, asymptotic analysis and numerical simulations","volume":"49","author":"Villa","year":"2021","journal-title":"Vietnam J. Math."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b101","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1038\/s41598-022-12500-1","article-title":"Model-based inference of metastatic seeding rates in de novo metastatic breast cancer reveals the impact of secondary seeding and molecular subtype","volume":"12","author":"Vitos","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.jtbi.2024.111957_b102","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b103","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/imammb\/14.1.39","article-title":"Mathematical modelling of avascular-tumour growth","volume":"14","author":"Ward","year":"1997","journal-title":"Math. Med. Biol."},{"key":"10.1016\/j.jtbi.2024.111957_b104","series-title":"Global cancer observatory","author":"World Health Organization","year":"2022"},{"issue":"40","key":"10.1016\/j.jtbi.2024.111957_b105","doi-asserted-by":"crossref","first-page":"16103","DOI":"10.1073\/pnas.1314385110","article-title":"Cell motility and drug gradients in the emergence of resistance to chemotherapy","volume":"110","author":"Wu","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jtbi.2024.111957_b106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029336","article-title":"Intra-and inter-tumor heterogeneity of BRAFV600E mutations in primary and metastatic melanoma","volume":"7","author":"Yancovitz","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jtbi.2024.111957_b107","first-page":"720","article-title":"A review of mathematical models for tumor dynamics and treatment resistance evolution of solid tumors","volume":"8","author":"Yin","year":"2019","journal-title":"CPT: Pharmacomet. Syst. Pharmacol."},{"issue":"14","key":"10.1016\/j.jtbi.2024.111957_b108","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1158\/1078-0432.CCR-07-0658","article-title":"Predicting human tumor drug concentrations from a preclinical pharmacokinetic model of temozolomide brain disposition","volume":"13","author":"Zhou","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jtbi.2024.111957_b109","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2018.10.014","article-title":"Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance","volume":"291","author":"Ziemys","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jtbi.2024.111957_b110","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00997","article-title":"Application of pharmacokinetic-pharmacodynamic modeling in drug delivery: development and challenges","volume":"11","author":"Zou","year":"2020","journal-title":"Front. Pharmacol."}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002251932400242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002251932400242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:31:28Z","timestamp":1777422688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002251932400242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":110,"alternative-id":["S002251932400242X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2024.111957","relation":{},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development of drug resistance in metastatic tumours under chemotherapy: An evolutionary perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2024.111957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111957"}}